Literature DB >> 3811012

Gastrointestinal hormones in alcoholic patients with and without liver disease.

W W Dinsmore, M E Callender, A H Love, K D Buchanan.   

Abstract

To assess the effects of both alcoholism and liver disease on gastroentero-pancreatic hormones, fasting and post-prandial concentrations were analysed in the following four groups: (1) Alcoholic subjects with liver disease; (2) Alcoholic subjects without liver disease; (3) Control subjects with liver disease; (4) Control subjects without liver disease.Liver disease was associated with increased fasting serum glucose, plasma insulin, pancreatic polypeptide, gastrin and vasoactive intestinal polypeptide. Alcoholism in the absence of liver disease did not influence either the fasting or post-prandial concentrations of serum glucose, plasma gastrin, insulin, pancreatic polypeptide, gastric inhibitory polypeptide, N- and C-terminal glucagon or vasoactive intestinal polypeptide. Alcoholism with liver disease depressed plasma gastric inhibitory polypeptide concentrations. The results suggest that the abnormalities in gastroenteropancreatic hormone in alcoholics are likely to be related to liver disease which is often concurrent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3811012      PMCID: PMC2448339     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  16 in total

1.  The mechanism by which alcohol stimulates acid secretion.

Authors:  W T IRVINE; D B WATKIN; E J WILLIAMS
Journal:  Gastroenterology       Date:  1960-07       Impact factor: 22.682

2.  Alcohol as a gastric secretory stimulant.

Authors:  E R WOODWARD; C ROBERTSON; H D RUTTENBERG; H SCHAPIRO
Journal:  Gastroenterology       Date:  1957-04       Impact factor: 22.682

Review 3.  Epidemiology of alcoholic liver disease.

Authors:  W K Lelbach
Journal:  Prog Liver Dis       Date:  1976

4.  Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide".

Authors:  R A Pederson; J C Brown
Journal:  Gastroenterology       Date:  1972-03       Impact factor: 22.682

5.  Glucose tolerance and diabetes in chronic liver disease.

Authors:  C Megyesi; E Samols; V Marks
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

6.  Antibodies to unconjugated synthetic and natural secretins.

Authors:  K D Buchanan; J D Teale; G Harper
Journal:  Horm Metab Res       Date:  1972-11       Impact factor: 2.936

7.  Pancreatic function and intestinal absorption in chronic alcoholism.

Authors:  E Mezey; E Jow; R E Slavin; F Tobon
Journal:  Gastroenterology       Date:  1970-11       Impact factor: 22.682

8.  Hormone and metabolite profiles in alcoholic liver disease.

Authors:  A Stewart; D G Johnston; K G Alberti; M Nattrass; R Wright
Journal:  Eur J Clin Invest       Date:  1983-10       Impact factor: 4.686

9.  Circulating levels of vasoactive intestinal polypeptide in liver disease.

Authors:  S Hunt; C A Vaamonde; T Rattassi; G Berian; S I Said; S Papper
Journal:  Arch Intern Med       Date:  1979-09

10.  Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentration.

Authors:  M M O'Hare; J G Daly; K D Buchanan
Journal:  Clin Chem       Date:  1983-11       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.